Literature DB >> 23603989

Highly prevalent TERT promoter mutations in bladder cancer and glioblastoma.

Xiaoli Liu, Guojun Wu, Yuan Shan, Christian Hartmann, Andreas von Deimling, Mingzhao Xing.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23603989      PMCID： PMC3680543          DOI： 10.4161/cc.24662

Source DB:  PubMed          Journal:  Cell Cycle        ISSN： 1551-4005            Impact factor:   4.534


× No keyword cloud information.
  5 in total

Review 1.  Telomerase RNA biosynthesis and processing.

Authors:  E M Smekalova; O S Shubernetskaya; M I Zvereva; E V Gromenko; M P Rubtsova; O A Dontsova
Journal:  Biochemistry (Mosc)       Date:  2012-10       Impact factor: 2.487

Review 2.  Telomerase and the search for the end of cancer.

Authors:  Simone Mocellin; Karen A Pooley; Donato Nitti
Journal:  Trends Mol Med       Date:  2012-12-17       Impact factor: 11.951

3.  TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal.

Authors:  Patrick J Killela; Zachary J Reitman; Yuchen Jiao; Chetan Bettegowda; Nishant Agrawal; Luis A Diaz; Allan H Friedman; Henry Friedman; Gary L Gallia; Beppino C Giovanella; Arthur P Grollman; Tong-Chuan He; Yiping He; Ralph H Hruban; George I Jallo; Nils Mandahl; Alan K Meeker; Fredrik Mertens; George J Netto; B Ahmed Rasheed; Gregory J Riggins; Thomas A Rosenquist; Mark Schiffman; Ie-Ming Shih; Dan Theodorescu; Michael S Torbenson; Victor E Velculescu; Tian-Li Wang; Nicolas Wentzensen; Laura D Wood; Ming Zhang; Roger E McLendon; Darell D Bigner; Kenneth W Kinzler; Bert Vogelstein; Nickolas Papadopoulos; Hai Yan
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-25       Impact factor: 11.205

4.  TERT promoter mutations in familial and sporadic melanoma.

Authors:  Susanne Horn; Adina Figl; P Sivaramakrishna Rachakonda; Christine Fischer; Antje Sucker; Andreas Gast; Stephanie Kadel; Iris Moll; Eduardo Nagore; Kari Hemminki; Dirk Schadendorf; Rajiv Kumar
Journal:  Science       Date:  2013-01-24       Impact factor: 47.728

5.  Highly recurrent TERT promoter mutations in human melanoma.

Authors:  Franklin W Huang; Eran Hodis; Mary Jue Xu; Gregory V Kryukov; Lynda Chin; Levi A Garraway
Journal:  Science       Date:  2013-01-24       Impact factor: 47.728
  5 in total
  64 in total

Review 1.  The evolving molecular genetics of low-grade glioma.

Authors:  Sriram Venneti; Jason T Huse
Journal:  Adv Anat Pathol       Date:  2015-03       Impact factor: 3.875

2.  In Japanese patients with papillary thyroid carcinoma, TERT promoter mutation is associated with poor prognosis, in contrast to BRAF V600E mutation.

Authors:  Almira Nasirden; Tsuyoshi Saito; Yuki Fukumura; Kieko Hara; Keisuke Akaike; Aiko Kurisaki-Arakawa; Miki Asahina; Atsushi Yamashita; Ran Tomomasa; Takuo Hayashi; Atsushi Arakawa; Takashi Yao
Journal:  Virchows Arch       Date:  2016-10-07       Impact factor: 4.064

Review 3.  Molecular Pathogenesis of Liver Cancer.

Authors:  Mehmet Ozturk; Tugce Batur; Umut Ekin; Aybike Erdogan; Evin İscan; Umur Keles; Ozden Oz; Cigdem Ozen
Journal:  J Gastrointest Cancer       Date:  2017-09

Review 4.  A second chance for telomerase reverse transcriptase in anticancer immunotherapy.

Authors:  Maurizio Zanetti
Journal:  Nat Rev Clin Oncol       Date:  2016-06-01       Impact factor: 66.675

5.  Frequent somatic mutations of the telomerase reverse transcriptase promoter in ovarian clear cell carcinoma but not in other major types of gynaecological malignancy.

Authors:  Ren-Chin Wu; Ayse Ayhan; Daichi Maeda; Kyu-Rae Kim; Blaise A Clarke; Patricia Shaw; Michael Herman Chui; Barry Rosen; Ie-Ming Shih; Tian-Li Wang
Journal:  J Pathol       Date:  2014-03       Impact factor: 7.996

6.  TERT promoter mutations and their association with BRAF V600E mutation and aggressive clinicopathological characteristics of thyroid cancer.

Authors:  Xiaoli Liu; Shen Qu; Rengyun Liu; Chunjun Sheng; Xiaoguang Shi; Guangwu Zhu; Avaniyapuram Kannan Murugan; Haixia Guan; Hongyu Yu; Yangang Wang; Hui Sun; Zhongyan Shan; Weiping Teng; Mingzhao Xing
Journal:  J Clin Endocrinol Metab       Date:  2014-03-11       Impact factor: 5.958

7.  Frequent somatic TERT promoter mutations in thyroid cancer: higher prevalence in advanced forms of the disease.

Authors:  Iñigo Landa; Ian Ganly; Timothy A Chan; Norisato Mitsutake; Michiko Matsuse; Tihana Ibrahimpasic; Ronald A Ghossein; James A Fagin
Journal:  J Clin Endocrinol Metab       Date:  2013-07-05       Impact factor: 5.958

8.  A Glioblastoma Genomics Primer for Clinicians.

Authors:  John D Patterson; Thidathip Wongsurawat; Analiz Rodriguez
Journal:  Med Res Arch       Date:  2020-02-21

Review 9.  Telomerase promoter mutations in cancer: an emerging molecular biomarker?

Authors:  João Vinagre; Vasco Pinto; Ricardo Celestino; Marta Reis; Helena Pópulo; Paula Boaventura; Miguel Melo; Telmo Catarino; Jorge Lima; José Manuel Lopes; Valdemar Máximo; Manuel Sobrinho-Simões; Paula Soares
Journal:  Virchows Arch       Date:  2014-07-22       Impact factor: 4.064

Review 10.  TERT promoter mutations in thyroid cancer.

Authors:  Rengyun Liu; Mingzhao Xing
Journal:  Endocr Relat Cancer       Date:  2016-01-05       Impact factor: 5.678
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.